Zenocutuzumab

zenocutuzumab · Merus B.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Zenocutuzumab, covering 2025-04-29 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers [Phase 2]